Star Sports Medicine Co., Ltd. (Hong Kong: 01609) filed its Monthly Return for August 2026, confirming stable capital metrics and full compliance with the Hong Kong Stock Exchange’s public-float rules.

• Authorised / Registered Capital: The company’s authorised share capital remained unchanged at 54.83 million ordinary H shares with a par value of RMB 1.00 each, representing registered capital of RMB 54.83 million.

• Issued Shares: As of 31 August 2026, the issued share count stood at 54.83 million shares, identical to the prior month. The issuer held no treasury shares, and no new shares were issued, repurchased, or cancelled during the period.

• Capital-Raising Instruments: The report confirms there were no outstanding or newly granted share options, warrants, convertible securities, or other equity-linked instruments.

• Public Float: Management certified that the company met the Main Board’s minimum public-float threshold of 25% of issued H shares as required under Rule 13.32D(1).

• Filing Details: The return, dated 3 September 2026, was submitted by Joint Company Secretary Liang Xiaodan, with all standard regulatory confirmations provided.

Overall, Star Sports Medicine closed August with an unchanged capital structure and affirmed regulatory compliance, signaling operational stability in its equity profile.